Home / News / India News / Article / Third phase trials of COVID-19 vaccine Covaxin begin

Third phase trials of COVID-19 vaccine Covaxin begin

Mid Day Short Description

  • WhatsAppBookmarkBookmark
Listen to this article :
Photo for representational purpose

Photo for representational purpose

Vaccine maker Bharat Biotech on Monday announced that it has commenced Phase-3 trials of Covaxin, India's first indigenous vaccine for COVID-19.

The Phase-3 trials, which involve 26,000 volunteers across India, are being conducted in partnership with the Indian Council of Medical Research (ICMR).

Read Next Story
Supreme Court declines to interfere in Army postings›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All